Who is Baysient?
Baysient creates cloud-based software to facilitate individualized dosing of anti-inflammatory MAbs to improve outcomes in patients with inflammatory diseases like IBD. Baysient’s software utilizes a pioneering Compuceutical approach with Bayesian models, routine lab results and demographic information to allow physicians to individualize dosing to a specific target trough level.
Why Baysient?
How Does It Work?
Schedule a Demo
Interested in how iDose can improve your patient outcomes?
Diane R. Mould, PhD
Dr. Diane R. Mould, Chief Scientific Officer (CSO) of Baysient, discusses individual variability in infliximab excretion and elimination. The variations seen in the individual pharmacokinetics of biologics highlight the need for more prospective data to further support effective personalized dosing. By focusing on important, modifiable factors for regulating drug levels, we can improve the efficacy of inflammatory disease treatments in clinical settings.
Latest Blog Post
Final Ruling: CLIA, Not FDA, Governs Therapeutic Drug Monitoring
In March 2025, a federal district court issued a landmark ruling that reaffirmed a critical distinction in healthcare regulation: clinical laboratory services are not medical devices. The ruling struck down the FDA’s attempt to expand its authority over lab-developed tests (LDTs), finding the agency had…
